Postpartum depression, a mental health condition affecting millions of new mothers, may soon be easier to diagnose and treat, thanks to a new blood test. Currently, postpartum depression is diagnosed ...

The first-ever drug for postpartum depression, containing a derivative of progesterone, received US Food and Drug Administration approval in 2019. That marked a new approach to the disorder. This ...

Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...

Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third ...

Postpartum depression affects some one in eight women in the United States. It typically occurs in the first weeks after childbirth, after a sudden drop in levels of estrogen and progesterone.

Adolescents with depression have higher levels of certain molecules in their blood than those without the condition. The finding could help identify teenagers who are more susceptible to depression, ...

New postpartum depression research from the University of Virginia School of Medicine and Weill Cornell Medicine could lead to a blood test to identify women at risk and possibly even to a preventive ...

A one-minute EEG test could one day help diagnose depression from patients’ homes. The corresponding study was published in Scientific Reports. Depression is primarily diagnosed via interviews and ...

A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and mini-brain models reveal a hidden neuroimmune story.